Fig. 1: Hematological responses according to the presence of CPC in the autograft.
From: Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients
Disease responses for the CPC+ and CPC− groups prior to transplant, at day 100 post-transplant and at best response post-transplant.
